04/25/2024 4:17 PM | Akebia Therapeutics (Filer)
| Form DEF 14A | |
04/25/2024 4:18 PM | Akebia Therapeutics (Filer)
| Form DEFA14A | |
04/25/2024 4:19 PM | Akebia Therapeutics (Filer)
| Form ARS | |
04/23/2024 7:32 AM | Akebia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/16/2024 6:33 AM | Akebia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/14/2024 4:19 PM | Akebia Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/01/2024 4:48 PM | Akebia Therapeutics (Issuer) Hadas Nicole R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/01/2024 4:49 PM | Akebia Therapeutics (Issuer) Dahan Michel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 4:46 PM | Akebia Therapeutics (Issuer) Burke Steven Keith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 4:47 PM | Akebia Therapeutics (Issuer) Butler John P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 5:00 PM | Akebia Therapeutics (Issuer) Butler John P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 5:01 PM | Akebia Therapeutics (Issuer) Burke Steven Keith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 5:02 PM | Akebia Therapeutics (Issuer) Dahan Michel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 5:03 PM | Akebia Therapeutics (Issuer) Hadas Nicole R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 3:32 PM | Akebia Therapeutics (Subject) Butler John P. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024 5:11 PM | Akebia Therapeutics (Subject) Butler John P. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024 5:14 PM | Akebia Therapeutics (Subject) Burke Steven Keith (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024 5:16 PM | Akebia Therapeutics (Subject) Dahan Michel (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024 5:19 PM | Akebia Therapeutics (Subject) Hadas Nicole R. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 7:00 AM | Akebia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/01/2024 3:52 PM | Akebia Therapeutics (Subject) Butler John P. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024 3:40 PM | Akebia Therapeutics (Subject) Burke Steven Keith (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024 7:05 AM | Akebia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/18/2024 4:21 PM | Akebia Therapeutics (Issuer) Grund Nicholas (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/18/2024 3:21 PM | Akebia Therapeutics (Issuer) Malabre Richard C (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/08/2024 7:02 AM | Akebia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/21/2023 4:07 PM | Akebia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/08/2023 6:45 AM | Akebia Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/08/2023 6:33 AM | Akebia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/02/2023 3:34 PM | Akebia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/12/2023 7:31 AM | Akebia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/26/2023 3:47 PM | Akebia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/28/2023 7:55 AM | Akebia Therapeutics (Filer)
| Form 10-K/A | |
08/28/2023 7:57 AM | Akebia Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/25/2023 7:14 AM | Akebia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/11/2023 6:35 AM | Akebia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/18/2023 3:30 PM | Akebia Therapeutics (Issuer) Snow Ellen (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
07/18/2023 6:47 AM | Akebia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/13/2023 6:04 AM | Akebia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/08/2023 3:30 PM | Akebia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2023 6:31 AM | Akebia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Biden replacement revealed? (Ad) A former CIA insider just announced a disturbing prediction…
Biden will withdraw as the Democrat nominee on June 13. See his shocking evidence in this new report |
06/02/2023 7:01 AM | Akebia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/31/2023 7:00 AM | Akebia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/30/2023 6:34 AM | Akebia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/25/2023 8:01 PM | Akebia Therapeutics (Issuer) Dahan Michel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/25/2023 8:01 PM | Akebia Therapeutics (Issuer) Hadas Nicole R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/25/2023 4:01 PM | Akebia Therapeutics (Subject) Hadas Nicole R. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/25/2023 3:44 PM | Akebia Therapeutics (Subject) Dahan Michel (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/25/2023 7:05 AM | Akebia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/23/2023 6:59 AM | Akebia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/18/2023 5:19 PM | Akebia Therapeutics (Issuer) Spellman David A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/18/2023 5:20 PM | Akebia Therapeutics (Issuer) Burke Steven Keith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2023 4:32 PM | Akebia Therapeutics (Subject) Burke Steven Keith (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2023 6:50 AM | Akebia Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/08/2023 6:40 AM | Akebia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2023 6:41 AM | Akebia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |